Seville Cohort of People Living With HIV at Risk for Anal Cancer
Launched by HOSPITALES UNIVERSITARIOS VIRGEN DEL ROCÍO · Oct 18, 2018
Trial Information
Current as of June 28, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The development of anal precancerous squamous intraepithelial lesions (SIL) and cancer of the anus is mainly caused by infection with high-risk human papillomavirus genotypes (HR-HPV). There is increasing awareness of marked (40 to 130-fold) risk of anal cancer in people living with HIV, especially among men who have sex with men (MSM). With the changing scenario of comorbidities in the HIV-infected population, given the success of modern antiretroviral therapy, anal cancer has emerged as a leading neoplasia across different cohorts in Western countries. In 2014, almost 30000 people were ne...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • HIV infection as confirmed by ELISA and western blot
- Exclusion Criteria:
- • Unable to provide informed consent
About Hospitales Universitarios Virgen Del Rocío
Hospitales Universitarios Virgen del Rocío is a leading healthcare institution in Spain, renowned for its commitment to excellence in patient care, medical research, and education. As a prominent clinical trial sponsor, it leverages its advanced facilities and a multidisciplinary team of experts to conduct innovative research aimed at improving therapeutic outcomes and advancing medical knowledge. The institution is dedicated to fostering collaboration between clinical practice and academic inquiry, ensuring that its trials adhere to the highest ethical standards and regulatory guidelines. With a focus on translating research findings into effective treatments, Hospitales Universitarios Virgen del Rocío plays a pivotal role in the advancement of healthcare and the well-being of patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seville, , Spain
Patients applied
Trial Officials
Pompeyo Viciana, MD, PhD
Study Director
Clínica El Sur
Karin Neukam, PharmD, PhD
Study Chair
Hospitales Universitarios Virgen del Rocío
César Sotomayor de la Piedra
Principal Investigator
Hospitales Universitarios Virgen del Rocío
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials